$492 Million is the total value of 5AM Venture Management, LLC's 16 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 33.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VOR | VOR BIOPHARMA INC | $104,937,000 | -15.9% | 6,692,429 | 0.0% | 21.31% | -32.2% | |
| New | RALLYBIO CORP | $73,673,000 | – | 4,190,724 | +100.0% | 14.96% | – | |
| AKUS | AKOUOS INC | $48,016,000 | -7.5% | 4,135,784 | 0.0% | 9.75% | -25.4% | |
| FIXX | HOMOLOGY MEDICINES INC | $35,698,000 | +8.3% | 4,535,919 | 0.0% | 7.25% | -12.7% | |
| IDYA | Sell | IDEAYA BIOSCIENCES INC | $35,637,000 | -5.6% | 1,398,066 | -22.2% | 7.24% | -23.8% |
| IMPL | IMPEL NEUROPHARMA INC | $35,137,000 | +37.6% | 2,884,791 | 0.0% | 7.14% | +11.1% | |
| ARVN | ARVINAS INC | $32,872,000 | +6.7% | 400,000 | 0.0% | 6.68% | -13.9% | |
| CABA | Sell | CABALETTA BIO INC | $28,689,000 | +11.8% | 2,359,263 | -20.9% | 5.82% | -9.8% |
| CRNX | CRINETICS PHARMACEUTICALS IN | $28,676,000 | +11.7% | 1,362,286 | 0.0% | 5.82% | -9.9% | |
| SCPH | SCPHARMACEUTICALS INC | $25,479,000 | +8.8% | 3,831,474 | 0.0% | 5.17% | -12.2% | |
| RNA | New | AVIDITY BIOSCIENCES INC | $13,683,000 | – | 555,555 | +100.0% | 2.78% | – |
| ISEE | New | IVERIC BIO INC | $12,505,000 | – | 770,000 | +100.0% | 2.54% | – |
| JANX | JANUX THERAPEUTICS INC | $9,653,000 | -13.3% | 446,266 | 0.0% | 1.96% | -30.0% | |
| FVAM | 5 01 ACQUISITION CORP | $3,586,000 | -1.5% | 365,126 | 0.0% | 0.73% | -20.5% | |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $2,541,000 | -37.3% | 1,134,511 | -43.5% | 0.52% | -49.4% |
| SBTX | New | SILVERBACK THERAPEUTICS INC | $1,694,000 | – | 169,748 | +100.0% | 0.34% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HOMOLOGY MEDICINES INC | 16 | Q3 2023 | 26.6% |
| ARVINAS INC | 16 | Q3 2023 | 14.3% |
| Crinetics Pharmaceuticals, Inc. | 16 | Q3 2023 | 12.8% |
| SCPHARMACEUTICALS INC | 16 | Q3 2023 | 7.5% |
| CIDARA THERAPEUTICS INC | 16 | Q3 2023 | 1.7% |
| IDEAYA BIOSCIENCES INC | 14 | Q1 2023 | 11.4% |
| VOR BIOPHARMA INC | 11 | Q3 2023 | 51.9% |
| CABALETTA BIO INC | 11 | Q2 2022 | 14.2% |
| AKOUOS INC | 10 | Q3 2022 | 27.7% |
| IMPEL PHARMACEUTICALS INC | 10 | Q3 2023 | 7.1% |
View 5AM Venture Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-03 |
| 13F-HR | 2021-11-15 |
View 5AM Venture Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.